Race and Socioeconomic Status Regulate Lifetime Risk of Atrial Fibrillation

Overview

Journal Circ Arrhythm Electrophysiol

Specialty Cardiology & Vascular Diseases

Date 2018 Jul 14

PMID 30002068

Citations 1

Authors

Mark D McCauley

Dawood Darbar

Affiliations

Soon will be listed here.

Citing Articles

Association Between Obesity-Mediated Atrial Fibrillation and Therapy With Sodium Channel Blocker Antiarrhythmic Drugs.

Ornelas-Loredo A, Kany S, Abraham V, Alzahrani Z, Darbar F, Sridhar A JAMA Cardiol. 2019; 5(1):57-64.

PMID: 31774463 PMC: 6902234. DOI: 10.1001/jamacardio.2019.4513.

References

Nattel S, Dobrev D . Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation. Nat Rev Cardiol. 2016; 13(10):575-90. DOI: 10.1038/nrcardio.2016.118. View

Mou L, Norby F, Chen L, ONeal W, Lewis T, Loehr L . Lifetime Risk of Atrial Fibrillation by Race and Socioeconomic Status: ARIC Study (Atherosclerosis Risk in Communities). Circ Arrhythm Electrophysiol. 2018; 11(7):e006350. PMC: 6053683. DOI: 10.1161/CIRCEP.118.006350. View

Alonso A, Krijthe B, Aspelund T, Stepas K, Pencina M, Moser C . Simple risk model predicts incidence of atrial fibrillation in a racially and geographically diverse population: the CHARGE-AF consortium. J Am Heart Assoc. 2013; 2(2):e000102. PMC: 3647274. DOI: 10.1161/JAHA.112.000102. View

Alonso A, Agarwal S, Soliman E, Ambrose M, Chamberlain A, Prineas R . Incidence of atrial fibrillation in whites and African-Americans: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J. 2009; 158(1):111-7. PMC: 2720573. DOI: 10.1016/j.ahj.2009.05.010. View

Chen L, Sotoodehnia N, Buzkova P, Lopez F, Yee L, Heckbert S . Atrial fibrillation and the risk of sudden cardiac death: the atherosclerosis risk in communities study and cardiovascular health study. JAMA Intern Med. 2013; 173(1):29-35. PMC: 3578214. DOI: 10.1001/2013.jamainternmed.744. View

Bukari A, Nayak H, Aziz Z, Deshmukh A, Tung R, Ozcan C . Impact of race and gender on clinical outcomes of catheter ablation in patients with atrial fibrillation. Pacing Clin Electrophysiol. 2017; 40(10):1073-1079. PMC: 5810413. DOI: 10.1111/pace.13165. View

Wolbrette D . Antiarrhythmic Drugs: Age, Race, and Gender Effects. Card Electrophysiol Clin. 2017; 2(3):369-378. DOI: 10.1016/j.ccep.2010.06.007. View

Huang H, Darbar D . Genetic heterogeneity of atrial fibrillation susceptibility loci across racial or ethnic groups. Eur Heart J. 2017; 38(34):2595-2598. PMC: 5837825. DOI: 10.1093/eurheartj/ehx289. View

Chugh S, Havmoeller R, Narayanan K, Singh D, Rienstra M, Benjamin E . Worldwide epidemiology of atrial fibrillation: a Global Burden of Disease 2010 Study. Circulation. 2013; 129(8):837-47. PMC: 4151302. DOI: 10.1161/CIRCULATIONAHA.113.005119. View

10.

Lloyd-Jones D, Wang T, Leip E, Larson M, Levy D, Vasan R . Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation. 2004; 110(9):1042-6. DOI: 10.1161/01.CIR.0000140263.20897.42. View

11.

Yu B, Zheng Y, Alexander D, Manolio T, Alonso A, Nettleton J . Genome-wide association study of a heart failure related metabolomic profile among African Americans in the Atherosclerosis Risk in Communities (ARIC) study. Genet Epidemiol. 2013; 37(8):840-5. PMC: 4079107. DOI: 10.1002/gepi.21752. View

12.

Schnabel R, Kerr K, Lubitz S, Alkylbekova E, Marcus G, Sinner M . Large-scale candidate gene analysis in whites and African Americans identifies IL6R polymorphism in relation to atrial fibrillation: the National Heart, Lung, and Blood Institute's Candidate Gene Association Resource (CARe) project. Circ Cardiovasc Genet. 2011; 4(5):557-64. PMC: 3224824. DOI: 10.1161/CIRCGENETICS.110.959197. View

13.

Russo A, Hafley G, Lee K, Stamato N, Lehmann M, Page R . Racial differences in outcome in the Multicenter UnSustained Tachycardia Trial (MUSTT): a comparison of whites versus blacks. Circulation. 2003; 108(1):67-72. DOI: 10.1161/01.CIR.0000078640.59296.6F. View

14.

Mathew J, Sachs M, Katz R, Patton K, Heckbert S, Hoofnagle A . Fibroblast growth factor-23 and incident atrial fibrillation: the Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). Circulation. 2014; 130(4):298-307. PMC: 4108550. DOI: 10.1161/CIRCULATIONAHA.113.005499. View

15.

ODonnell M, Chin S, Rangarajan S, Xavier D, Liu L, Zhang H . Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study. Lancet. 2016; 388(10046):761-75. DOI: 10.1016/S0140-6736(16)30506-2. View

16.

Chen L, Shen W . Epidemiology of atrial fibrillation: a current perspective. Heart Rhythm. 2007; 4(3 Suppl):S1-6. DOI: 10.1016/j.hrthm.2006.12.018. View

17.

Burroughs V, Maxey R, Levy R . Racial and ethnic differences in response to medicines: towards individualized pharmaceutical treatment. J Natl Med Assoc. 2002; 94(10 Suppl):1-26. PMC: 2594139. View

18.

Amponsah M, Benjamin E, Magnani J . Atrial Fibrillation and Race - A Contemporary Review. Curr Cardiovasc Risk Rep. 2013; 7(5). PMC: 3815541. DOI: 10.1007/s12170-013-0327-8. View

19.

Perera K, Pearce L, Sharma M, Benavente O, Connolly S, Hart R . Predictors of Mortality in Patients With Atrial Fibrillation (from the Atrial Fibrillation Clopidogrel Trial With Irbesartan for Prevention of Vascular Events [ACTIVE A]). Am J Cardiol. 2018; 121(5):584-589. DOI: 10.1016/j.amjcard.2017.11.028. View